Client Zenas BioPharma and Royalty Pharma Enter Funding Agreement for Up to $300 Million
September 03, 2025
September 03, 2025
BOSTON, Massachusetts, Sept. 3 [Category: BizLaw/Legal] -- Ropes and Gray, a law firm, issued the following news:
* * *
Client Zenas BioPharma and Royalty Pharma Enter Funding Agreement for Up to $300 Million
*
Ropes & Gray advised Zenas BioPharma in securing up to $300 million in funding from Royalty Pharma in exchange for a 5.5 percent royalty on worldwide net sales of lead autoimmune candidate obexelimab in partnered geographies. The fin . . .
* * *
Client Zenas BioPharma and Royalty Pharma Enter Funding Agreement for Up to $300 Million
*
Ropes & Gray advised Zenas BioPharma in securing up to $300 million in funding from Royalty Pharma in exchange for a 5.5 percent royalty on worldwide net sales of lead autoimmune candidate obexelimab in partnered geographies. The fin . . .